Baxter International intends to expand three sterile injectable manufacturing facilities it got in its $625 million deal for Claris Injectables.

Dr. Reddy's CEO GV Prasad says the generic drugmaker’s top priority is to do what is needed to get its manufacturing up to FDA expectations.

French drug regulators slapped Chinese API maker Chongqing Succeway Pharmaceutical with a warning letter and issued a recall following an inspection last month…

AstraZeneca is investing $77 million to expand asthma drug production at its Sydney plant, citing rising demand from China.

Gilead hit with revived lawsuit claiming it sourced a key HIV drug ingredient from an unapproved Chinese manufacturer.

UAE-based Neopharma plans to build a $100 million plant in Abu Dhabi after recently picking up a plant in Japan.

The European Medicines Agency has approved the continuous manufacturing production of the HIV drug Prezista (darunavir) by Janssen Pharmaceuticals, a unit of…

Switzerland-based CDMO Lonza said it has been given the green light by regulators for its $5.5 billion deal to buy U.S.-based contract capsule and drug…